相关实验视频
Updated: Jul 14, 2026

07:54
A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
Published on: July 25, 2017
14.3K
双细菌长子物种 双菌长子物种 婴儿用品 YLGB-1496-毒理学评价
Jian Zhao1, Yueyi Guo1, Qiuyue Jiang2
1Beijing Key Laboratory of Bioactive Substances and Functional Foods, Beijing Union University, Beijing, China.
Journal of applied toxicology : JAT
|September 10, 2024
概括
作为一种潜在的益生菌,Bifidobacterium infantis YLGB-1496在基因毒性和老鼠毒性研究中证明了其安全性. 这些发现支持其在婴儿配方奶粉中的使用.
科学领域:
- 微生物学 微生物学
- 毒理学 毒理学 毒理学
- 益生菌研究的研究.
背景情况:
- 双杆菌婴儿YLGB-1496是一种从人类母乳中分离出来的细菌菌株.
- 需要进行广泛的研究来评估潜在益生菌菌株的安全性.
研究的目的:
- 为了评估Bifidobacterium infantis YLGB-1496作为益生菌的安全性.
- 进行基因毒性测定和13周口服大鼠毒性研究.
主要方法:
- 进行了艾姆斯试验,体内小鼠微核试验和体内小鼠精子细胞染色体异常试验.
- 在Sprague-Dawley大鼠中,B. infantis YLGB-1496被口服,剂量高达1.5g/kg/天,持续了13周.
主要成果:
- 在任何测定中,B. infantis YLGB-1496都没有显示出任何基因毒性活性.
- 在13周的毒性研究中,在老鼠中没有观察到与治疗相关的不良反应.
- 没有发现转移或致病性方面的问题.
结论:
- 安全性评估表明,与B. infantis YLGB-1496.6.相关的不良影响没有.
- 结果支持B. infantis YLGB-1496作为婴儿配方奶粉中的益生菌的潜在使用.
相关概念视频
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Bacterial Phylum Proteobacteria
Proteobacteria, one of the largest and most diverse bacterial phyla, encompasses a wide range of Gram-negative bacteria distinguished by their outer membrane composed of lipopolysaccharides. These microorganisms exhibit various metabolic capabilities, including phototrophy, chemolithotrophy, and heterotrophy, and thrive in diverse environments from soil to aquatic systems and host-associated niches. The phylum is divided into six classes: Alphaproteobacteria, Betaproteobacteria,...
Bacterial Phylum Firmicutes
Firmicutes is a diverse phylum of Gram-positive bacteria characterized by a low GC content in their genomes. This phylum includes organisms with monoderm or diderm cell envelopes, highlighting a complex evolutionary history. Firmicutes comprises several major orders, including Lactobacillales, Clostridiales, and Bacillales, which exhibit remarkable diversity in their morphology, metabolism, and ecological roles.The order Lactobacillales includes lactic acid bacteria, which are fermentative...
Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...

